INTRODUCTION
Mammalian sexual development is characterized by three distinct, sequential events: the establishment of chromosomal sex at fertilization (XY or XX), gonadal development and differentiation (testis or ovary), and finally, the acquisition of the proper sexual phenotype (male or female). Several transcription factors are known to have crucial roles in gonadal development and sex determination and differentiation: the testis determining factor, Sry; the Sry-related factor, Sox9; steroidogenic factor 1, SF-1; Wilms' tumor-1, WT-1; the LIM-homeobox factor, Lhx9; and the nuclear receptor, Dax-1 [1] [2] [3] . In addition to these factors, the list of genes proposed to be implicated in these fundamental developmental processes continues to grow. Examples of the latter include the double-sex and mab-3-related transcription factor 1 (Dmrt-1) and the zinc finger factor GATA-4 [4] [5] [6] [7] .
The X-linked Dax-1 gene encodes an atypical member of the nuclear receptor superfamily in which the characteristic N-terminal zinc finger region required for DNA binding is absent and is replaced by a stretch of 3.5 repeats of a 65-67 amino acid motif [8] . Dax-1 is expressed in several endocrine tissues [9] , including the gonads, where it is present in Sertoli and Leydig cells of the testis and granulosa and theca cells of the ovary [9] [10] [11] . Dax-1 plays a critical role in adrenal development and gonadal function; it was originally identified as the causative gene for adrenal hypoplasia congenita (AHC), which is associated with hypogonadotropic hypogonadism (HHG), a recessive disorder affecting males [9, 10, 12, 13] . Indeed, several groups have characterized numerous Dax-1 mutations (nucleotide substitutions, insertions, and deletions) in individuals affected with AHC and HHG [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Females carrying heterozygous mutations in the Dax-1 gene are normal and there has been no report of homozygous females because males needed to transmit the nonfunctional allele are infertile. Because Dax-1 gene expression is rapidly down-regulated in the developing male gonad immediately after overt testis differentiation in the mouse [10] , the Dax-1 gene was initially believed to be an important ovarian determinant. However, in Dax-1-deficient mice, all females were characterized as phenotypically normal [25] . It is interesting that all male Dax-1-deficient mice were hypogonadal despite normal gonadotropin levels, suggesting a primary testicular defect [25] . Indeed, male Dax-1-deficient mice exhibited a complete loss of germ cells by 14 wk, resulting in sterility [25] . Thus, Dax-1 is apparently not required for ovarian differentiation, but rather is essential for the maintenance of the integrity of the seminiferous epithelium of the testis [25] . In addition to Dax-1 mutations, another human disorder has been associated with the Dax-1 gene. In this case, duplication of a small region on the X chromosome that encompasses the Dax-1 gene leads to dosage-sensitive sex reversal in XY males [26] . In certain situations, overexpression of Dax-1 in vivo can result in sex reversal by antagonizing the action of Sry [27] . Thus, adequate Dax-1 levels are required for normal testis function, but too much Dax-1 appears to have an ''anti-testis'' effect.
At a transcriptional level, Dax-1 was shown to block steroidogenesis at multiple levels by acting as a potent repressor. Dax-1 transcriptional repression can occur through two different mechanisms. First, Dax-1 has been shown to bind DNA hairpin structures found in its promoter, as well as in the promoter of other target genes, to repress transcription [28] . Second, Dax-1 directly interacts, through its N-terminal region, with the orphan nuclear receptor, SF-1, leading to a repression of SF-1-dependent transcription [29] [30] [31] . In fact, Dax-1 serves as an adaptor molecule because it recruits via its C-terminal domain, the nuclear receptor corepressors, N-CoR and Alien [29, 32] . It is inter-esting that this Dax-1 C-terminal repression domain is absent or mutated in patients with AHC and, consequently, Dax-1 can no longer recruit corepressors [31, 33] . Thus, transcriptional silencing by Dax-1 appears to be essential for normal steroidogenic function.
GATA-4 is a member of a new class of transcriptional regulators (called the GATA factors), which have recently been shown to be expressed in the gonads [4, [34] [35] [36] . Six vertebrate GATA factors (GATA-1 to GATA-6) have been identified [37] . They act as transcriptional activators by binding to consensus GATA motifs [(A/T)GATA(A/G)] found in the promoter region of numerous target genes. Complementary in vitro and in vivo approaches have established that these factors play essential functions in cell differentiation, organ morphogenesis, and tissue-specific gene expression [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] . Three GATA factors are expressed in the gonads: GATA-1 [4, 36] , GATA-4 [4, 35] , and GATA-6 [34] . GATA-1 and GATA-4 are both found in Sertoli cells but at different stages of development; GATA-1 is primarily expressed in postnatal Sertoli cells [4, 36] , whereas GATA-4 is abundantly expressed in Sertoli cells from the onset of gonadal development until shortly after birth [4] . The GATA-4 expression pattern strikingly correlates with that of MIS, a crucial Sertoli cell hormone required for Müllerian duct regression, and hence, proper male sex differentiation. Indeed, we have identified the MIS promoter as the first known target for GATA-4 in fetal Sertoli cells [4] . GATA-4 can activate the MIS promoter on its own but also physically interacts, via its zinc finger domain, with the orphan nuclear receptor, SF-1, to synergistically activate MIS transcription [5] . GATA factors are also expressed in the mouse ovary [4, 34] ; target genes, however, remain to be identified.
Although GATA-4, SF-1, and Dax-1 are all coexpressed in Sertoli cells from the earliest stages of gonadal development, the combinatorial effect of these factors on the activity of gonadal target promoters has not been assessed.
MATERIALS AND METHODS

Plasmids
The Ϫ180 base pair [bp], Ϫ107 bp, Ϫ83 bp, and Ϫ65 bp murine MIS-luciferase promoter constructs were obtained by polymerase chain reaction (PCR) on mouse genomic DNA as previously described [5] . The Ϫ180mut construct, which was obtained by site-directed mutagenesis, contains a mutation (GATA→GGTA) in the consensus MIS promoter GATA element at Ϫ75 bp. Shorter versions of this construct, Ϫ107mut and Ϫ83mut, were obtained by PCR using the Ϫ180mut plasmid as a template. The 3ϫ(SF-1:GATA)-MIS luciferase reporter contains three copies of the MIS SF-1 and GATA elements in their natural context, cloned upstream of the minimal MIS promoter (MIS min ) [5] . The minimal POMC (POMC min ), 3ϫSF-1-POMC min , and Ϫ142 bp LH␤ luciferase reporters were kindly provided by Jacques Drouin [47] [48] [49] . In the 3ϫSF-1-POMC min construct, SF-1 refers to the SF-1 binding element found in the bovine LH␤ promoter [47] . The 2ϫGATA:3ϫSF-1-POMC min promoter construct was obtained by cloning two consensus GATA elements upstream of the 3ϫSF-1-POMC min reporter. The 2ϫGATA-POMC min luciferase reporter was generated by cloning two copies of the MIS GATA element (sense oligonucleotide, 5Ј-GATCCTGGTGTTGATAGGGGCGTA-3Ј; antisense oligonucleotide, 5Ј-GATCTACGCCCCTATCAACACCAG-3Ј) upstream of the minimal POMC promoter. Similarly, the 2ϫGATA-MIS min reporter was obtained by cloning two copies of the above-mentioned double-stranded oligonucleotide in front of the minimal MIS promoter. The 2ϫSF-1-MIS min reporter, which contains two copies of the MIS SF-1 element cloned upstream of the minimal MIS promoter, has been previously described [5] . The 2ϫGATA: 2ϫSF-1-MIS min promoter construct was made by cloning two copies of a consensus GATA element upstream of the 2ϫSF-1-MIS min reporter. An expression plasmid for GATA-4 was obtained by cloning a PCR fragment, corresponding to the GATA-4 open reading frame into the HindIII/XbaI sites of the Cytomegalovirus (CMV)-driven expression vector, pcDNA3 (Invitrogen, Carlsbad, CA). The PCR fragment was amplified using first-strand cDNA prepared from neonate testis RNA as a template for the PCR reaction (forward primer, 5Ј-TCAAGCTTCGAAGCTCAGAGCTTG-GGGCG-3Ј; reverse primer, 5Ј-TATCTAGACCGAGCA-GGAATTTGAAGAGGGAA-3Ј). A mouse Dax-1 expression plasmid was generated by PCR (forward oligo, 5Ј-GATCTAGACGAGGAGCCTCAGGCCATG-3Ј; reverse oligo, 5Ј-CAGGTACCTTCACAGCTTTGCACAGAG-3Ј) using first-strand cDNA prepared from ␣T3-1 cells. The ␣T3-1 cell line was kindly provided by Pamela Mellon [50] . An expression plasmid encoding the truncated Dax-1 protein (⌬Dax-1), which was deleted of its N-terminal region (⌬aa1-253), was also produced by PCR on the fulllength Dax-1 cDNA using the same 3Ј oligo described above but with a different 5Ј oligo (5Ј-CATCTAGACA-GGTGGTGTGCGAGGCAGCG-3Ј). All of our PCR-amplified expression vectors and promoter constructs were verified by sequencing. The SF-1 expression plasmid was kindly provided by Keith Parker [51] .
Isolation of Immature Sertoli Cells
Neonate Sertoli cells were prepared from 3-to 5-dayold Sprague-Dawley rats (Charles River Canada, St-Constant, PQ) using established procedures as outlined by Tung and Fritz [52] . Final Sertoli cell aggregates were resuspended in Eagle minimal essential medium (MEM) containing 10% fetal bovine serum (FBS). The cells were subsequently seeded at high density (2 ϫ 10 5 cells) in 24-well plastic dishes and cultured at 32ЊC under 5% CO 2 . The next morning, cells were rinsed with PBS to remove contaminating germ cells and then fresh media was added to the cells.
Cell Culture and Transfections
African green monkey kidney CV-1 cells were grown in Dulbecco modified Eagle medium (DMEM) supplemented with 10% newborn calf serum. Human choriocarcinoma JEG-3 cells were maintained in DMEM containing 10% FBS. All transfections were done in 24-well plates using the calcium phosphate precipitation method [53] . The day prior to transfection, CV-1, JEG-3, and neonate primary Sertoli cells were plated at densities of 2.2 ϫ 10 4 , 4 ϫ 10 4 , and 2 ϫ 10 5 , respectively. Cells were transfected 24 h after the initial plating. Culture media was changed 12-16 h after transfection and the cells were finally harvested the following morning (40-44 h after transfection). Cells were lysed by adding 50 l of lysis buffer (100 mM Tris-HCl pH 7.9, 0.5% Igepal [Sigma-Aldrich Canada, Oakville, ON], and 5 mM dithiothreitol) directly to the wells. An aliquot of the lysate was then assayed for luciferase activity using an EG&G Berthold LB 9507 luminometer and luciferine (BD Pharmingen, San Diego, CA) as substrate. In all experi- ments, the total amount of DNA was kept constant at 1.5 g per well using Sp64 (Promega, Madison, WI) as carrier DNA; several DNA preparations were used to ensure reproducibility of the results. Transfection efficiencies were monitored by cotransfection with a control ␤-galactosidase expression plasmid. Data reported represent the average of at least three experiments, each done in duplicate.
Production of MBP Fusion Proteins and In Vitro ProteinProtein Interaction Assays
A recombinant maltose-binding protein (MBP)-Dax-1 fusion protein was obtained by cloning the Dax-1 coding region in frame with MBP using the commercially available pMAL-c fusion protein vector (New England Biolabs, Mississauga, ON, Canada). The MBP-LacZ␣ fusion protein was produced by the pMAL-c vector without any cloned insert. The fusion proteins were produced and purified as previously described [5] . In vitro protein-protein interaction studies were performed as previously outlined [5] .
Statistical Analysis
With the exception of Figure 5A , statistical analyses were done by one-way ANOVA followed by a NewmanKeuls test to detect significant differences between groups. For the SF-1-dependent activation of multiple promoters in JEG-3 cells (Fig. 5A ), significant differences between the control and SF-1 activation groups were determined using Student t-test. For all statistical analyses, P Ͻ 0.05 was considered significant.
RESULTS
Dax-1 Specifically Represses SF-1-but Not GATA-4-Dependent Transactivation
Dax-1 represses SF-1-mediated transcription of promoters by acting as a bridging molecule between SF-1 and nuclear corepressors [29, 32] . Before determining the role of Dax-1 in modulating the transcriptional cooperation between GATA-4 and SF-1, we first tested the effect of Dax-1 on GATA-4-dependent transcription in heterologous CV-1 cells. As expected, Dax-1 efficiently repressed the transactivation induced by SF-1 on two separate SF-1 target promoters, the LH␤ promoter in its natural context (Fig. 1A,  left panel) , and a synthetic reporter composed of two copies of a consensus GATA element and three copies of an SF-1 element fused to the minimal pro-opiomelanocortin (POMC) promoter (Fig. 1A, right panel) . The repressive effect of Dax-1 was strictly dependent on the presence of SF-1 because Dax-1 alone had no effect on the SF-1-dependent promoters (hatched bars in Fig. 1A ). As shown in Figure 1B , Dax-1 did not affect GATA-4-dependent transactivation of two separate GATA-responsive reporters. This suggested that unlike SF-1, Dax-1 does not physically interact with GATA-4. To test this hypothesis, we performed an in vitro protein-protein interaction analysis between Dax-1 and GATA-4. Consistent with the fact that Dax-1 and SF-1 physically interact [29] [30] [31] , an in vitro synthesized, radiolabeled SF-1 protein was specifically retained on agarose beads coated with an MBP-Dax-1 fusion protein (Fig. 2) . The interaction was specific for the Dax-1 portion of the fusion protein because no labeled SF-1 was retained with a control MBP-LacZ␣ fusion protein. Similar experiments performed using a labeled GATA-4 protein revealed that GATA-4 and Dax-1 do not directly interact (Fig.  2, right panel) . These results taken together indicate that transcriptional repression by Dax-1 requires a direct interaction between Dax-1 and its interacting partner, SF-1.
Dax-1 Represses GATA/SF-1 Synergism in Heterologous Cells
We previously reported that GATA factors can enhance SF-1-dependent transcription through a synergistic interaction with SF-1 [5] . Because Dax-1 is coexpressed with GATA-4 and SF-1 in multiple gonadal cell types, Dax-1 may also be an important modulator of GATA/SF-1 synergism. The effect of increasing doses of Dax-1 on GATA-4/ SF-1 synergism was first tested in heterologous CV-1 cells (Fig. 3) . Dax-1 efficiently repressed GATA-4/SF-1 synergism on multiple SF-1 target promoters. They included the natural MIS promoter, which contains both GATA and SF-1 binding sites (Fig. 3, upper left panel) , two synthetic reporters consisting of multimerized GATA and SF-1 elements in different positions and fused to different minimal promoters (Fig. 3 , upper right and lower left panels), and a synthetic reporter containing only SF-1 binding sites (Fig.  3, lower right panel) . Because Dax-1 represses GATA-4/ SF-1 transcriptional synergism, Dax-1 must still interact with SF-1, despite the GATA-4/SF-1 interaction and regardless of whether or not GATA-4 is bound to DNA. Dax-1 repression is mediated either by the corepressor associated with Dax-1 or via a disruption of the GATA-4/SF-1 proteinprotein interaction. To assess the importance of a Dax-1/ SF-1 interaction for the repression of GATA-4/SF-1 synergism, we generated a Dax-1 mutant (⌬Dax-1) that was deleted of its entire N-terminal domain, the region previously shown to interact with SF-1 [29] [30] [31] . As shown in Figure 4 , the Dax-1 mutant no longer repressed GATA-4/ SF-1 synergism, confirming that a direct interaction between Dax-1 and SF-1 is required to blunt the transcriptional cooperation between GATA-4 and SF-1.
The effect of Dax-1 was subsequently tested in human choriocarcinoma JEG-3 cells. Because this cell line endogenously expresses GATA factors [54] , transfection of SF-1 alone leads to a potent GATA/SF-1 synergistic activation of multiple SF-1 target promoters when compared with similar transfections done in CV-1 cells, which are devoid of GATA activity (Fig. 5A) . In these cells, Dax-1 was also found to repress SF-1-dependent transactivation/synergism ( Fig. 5B) . The Dax-1-mediated repression was specific because Dax-1 alone had no effect on promoter activity (hatched bars in Fig. 5B) . Thus these results demonstrate that Dax-1 can also repress synergism between exogenously expressed SF-1 and endogenous GATA factors.
Dax-1 Blunts the Transcriptional Synergism Between Endogenous GATA-4 and SF-1 in Sertoli Cells
Having confirmed that Dax-1 can repress GATA/SF-1 synergism in a heterologous context, we next determined whether Dax-1 had similar actions in cells that normally express GATA-4 and SF-1. For this purpose, we transfected neonate primary Sertoli cell cultures, which endogenously express GATA-4, SF-1, MIS, and low levels of Dax-1 [11, 55, 56] with a target promoter we have previously shown GATA-4 and SF-1 to synergistically activate, the MIS promoter [5] . Therefore in transfected primary Sertoli cells, the wild-type MIS promoter is at a synergistic level of activation due to synergism of endogenous GATA-4 and SF-1. As shown in Figure 6 , increasing doses of Dax-1 resulted in a concomitant decrease in the activity of the Ϫ180 bp MIS promoter, and hence, endogenous GATA-4/ SF-1 synergism. Dax-1 repression was also observed on a similar MIS reporter containing a mutated GATA element (Ϫ180mut), indicating that Dax-1 can repress GATA-4/SF-1 synergism irrespective of whether or not GATA-4 is bound to DNA. Deletion of the Sox9 binding site (Ϫ107 bp and Ϫ107mut), did not abrogate the ability of Dax-1 to repress MIS promoter activity. Dax-1, however, could no longer repress transcription when the SF-1 binding site was deleted (Ϫ83 bp and Ϫ83mut). This is consistent with our data in heterologous cells (Fig. 1) , which showed that an intact SF-1 binding site was required to recruit Dax-1 and its associated corepressor to target promoters. Therefore, Dax-1 repression of MIS transcription in Sertoli cells is mediated, in part, through a disruption of GATA-4/SF-1 synergism.
DISCUSSION
Tissue-specific gene expression is controlled, in part, through unique combinatorial interactions, which may be synergistic or antagonistic, among different transcriptional regulators. The establishment of a proper sexual phenotype is a paradigm of how multiple transcription factors can come together to regulate a distinct set of genes at the appropriate time during development. The transcriptional mechanisms that regulate the expression of Müllerian inhibiting substance, a key hormone in the sex differentiation pathway, have been the focus of intensive study. The transcriptional regulatory elements required for tissue-specific expression of the MIS gene are contained within a short stretch of its proximal promoter region. They include binding sites for Sox9, SF-1, and GATA-4. We have previously reported that GATA-4, a member of the GATA family of transcription factors, regulates MIS transcription by directly binding to its consensus site on the MIS promoter and by a synergistic interaction with SF-1 [4, 5] . In the present study, we now show that Dax-1, an unusual member of the nuclear receptor superfamily, can modulate MIS transcription by disrupting GATA-4/SF-1 synergism in Sertoli cells.
In vitro and in vivo experiments have revealed that func-tional cooperation between Sox9, SF-1, WT-1, GATA-4, and Dax-1 regulates MIS transcription [5, 30, 57] . SF-1/ WT-1 [30] , SF-1/Sox9 [57] , and SF-1/GATA-4 interactions [5] all lead to enhanced MIS transcription. Dax-1 represses MIS transcription activity without binding to DNA [30] . Indeed, Dax-1 was shown to negatively modulate MIS promoter activity by disrupting SF-1/WT-1 synergism through a direct protein-protein interaction with DNA-bound SF-1 [30] . The present work also describes Dax-1 as a potent repressor of GATA-4/SF-1 synergism. Because Dax-1 did not directly affect GATA-4-dependent activation, the mechanism of Dax-1 repression was mediated through a direct interaction with SF-1. The fact that our Dax-1 deletion mutant (⌬Dax-1), which cannot interact with SF-1 [29] [30] [31] , had no effect on GATA-4/SF-1 synergism supports this conclusion. Taken together, our results indicate that Dax-1 acts not only as a repressor of SF-1-dependent transcription but also plays an important role as a negative modulator of transcriptional synergism between SF-1 and other transcription factors. The latter may be a key mechanism for finetuning the regulation of SF-1 target genes. We have used the MIS promoter as an example of a gonadal target gene; a model for Dax-1 repression is shown in Figure 7 . Similar repressive roles for Dax-1 likely exist in other SF-1 target tissues such as the pituitary, where transcriptional synergism involving either SF-1 and the homeoprotein, Pitx1 [48] , or SF-1 and the immediate early factor, Egr-1 [47, 58, 59] , has been shown to be an important constituent of LH␤ gene activation. GATA factors are coexpressed with SF-1 and Dax-1 in many tissues, including the testis, ovary, pituitary, and adrenal [4, 9, 11, 34, 35, 60] . We have previously reported that GATA/SF-1 synergism is not limited to the GATA-4 factor, but rather can occur with other GATA family members [5] . Moreover, we have observed that Dax-1 can also repress synergism between SF-1 and these other GATA factors (data not shown). Thus, Dax-1 acts as a negative modulator of GATA/SF-1 synergism. It is interesting that a similar inhibitory GATA cofactor, called FOG-2 (Friend-of-GATA, has also been described [61] [62] [63] . In the heart, FOG-2 is coexpressed with GATA-4, where it behaves as a potent repressor of GATA-4-dependent transcription [61] [62] [63] . We have recently observed that FOG-2 also colocalizes with GATA-4 in Sertoli cells, where it potently represses GATA-4/SF-1 synergism and MIS promoter activity in Sertoli cells (unpublished observations). In contrast to Dax-1, however, the transcriptional repression induced by FOG-2 is entirely mediated through a direct interaction with GATA-4.
Although the MIS hormone is primarily expressed during fetal life, it is also found in both the postnatal testis and ovary, albeit at much lower levels [64] . In adults, MIS has been proposed to regulate steroid hormone production by modulating the transcription of genes encoding steroidogenic enzymes [65] [66] [67] . Therefore, in addition to regulating sex differentiation, MIS appears to have a later role in maintaining steroid hormone production in the gonads. Consequently, the MIS gene must still be under tight transcriptional control at this later developmental time point. Because SF-1, Dax-1, and GATA factors continue to be expressed postnatally, combinatorial interactions between these factors are undoubtedly an integral component of this transcriptional control.
